Halozyme Therapeutics Inc (HALO)
45.73
-0.03
(-0.07%)
USD |
NASDAQ |
Nov 21, 16:00
45.82
+0.09
(+0.20%)
After-Hours: 18:20
Halozyme Therapeutics Max Drawdown (5Y): 49.06% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 49.06% |
September 30, 2024 | 49.06% |
August 31, 2024 | 49.06% |
July 31, 2024 | 49.06% |
June 30, 2024 | 49.06% |
May 31, 2024 | 49.06% |
April 30, 2024 | 49.06% |
March 31, 2024 | 49.06% |
February 29, 2024 | 49.06% |
January 31, 2024 | 49.06% |
December 31, 2023 | 49.06% |
November 30, 2023 | 49.06% |
October 31, 2023 | 49.06% |
September 30, 2023 | 49.06% |
August 31, 2023 | 49.06% |
July 31, 2023 | 49.06% |
June 30, 2023 | 49.06% |
May 31, 2023 | 49.06% |
April 30, 2023 | 46.14% |
March 31, 2023 | 46.14% |
February 28, 2023 | 46.14% |
January 31, 2023 | 46.14% |
December 31, 2022 | 46.14% |
November 30, 2022 | 46.14% |
October 31, 2022 | 46.14% |
Date | Value |
---|---|
September 30, 2022 | 46.14% |
August 31, 2022 | 47.86% |
July 31, 2022 | 52.48% |
June 30, 2022 | 52.48% |
May 31, 2022 | 52.48% |
April 30, 2022 | 52.48% |
March 31, 2022 | 52.48% |
February 28, 2022 | 52.48% |
January 31, 2022 | 52.48% |
December 31, 2021 | 59.64% |
November 30, 2021 | 60.08% |
October 31, 2021 | 66.38% |
September 30, 2021 | 66.38% |
August 31, 2021 | 66.38% |
July 31, 2021 | 66.38% |
June 30, 2021 | 66.38% |
May 31, 2021 | 68.57% |
April 30, 2021 | 68.57% |
March 31, 2021 | 68.57% |
February 28, 2021 | 68.57% |
January 31, 2021 | 71.03% |
December 31, 2020 | 71.03% |
November 30, 2020 | 71.03% |
October 31, 2020 | 71.03% |
September 30, 2020 | 71.03% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
46.14%
Minimum
Sep 2022
71.03%
Maximum
Nov 2019
57.65%
Average
52.48%
Median
Jan 2022
Max Drawdown (5Y) Benchmarks
Abbott Laboratories | 33.88% |
Novavax Inc | 98.82% |
Insulet Corp | 61.31% |
BioLife Solutions Inc | 85.14% |
TransMedics Group Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 7.939 |
Beta (5Y) | 1.292 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 44.40% |
Historical Sharpe Ratio (5Y) | 0.5544 |
Historical Sortino (5Y) | 1.117 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.38% |